Gene therapy in head and neck cancer: a review

Genes involved in the tumor protein 53 (TP53) and epidermal growth factor receptor (EGFR) pathways have been extensively investigated and many promising preclinical studies have shown tumor inhibition through genetic modulation. In contrast, cigarette smoking proved as significant characteristic of SCC (P =.0087). In contrast, cigarette smoking proved as significant characteristic of SCC (P = .0087). There are currently no other therapies that extend survival of patients with head and neck cancer that is resistant to cisplatin and has relapsed or spread (metastatic). These strategies often employ altered-fractionation radiation therapy or EBRT in various combinations with chemotherapy or brachytherapy. Recently, attention has moved towards cancer with the realisation that it too is a genetic disease. Schwartz GJ, Mehta RH, Wenig BL, et al: Salvage treatment for recurrent squamous cell carcinoma of the oral cavity.

The amount of the virus in tumor tissues 3 days after the injection was higher in tumors treated with HSV-1 RH2 and ultrasound than in tumors treated with RH2 only. Patients should receive a comprehensive oral evaluation several weeks prior to initiation of highdose upper-mantle radiation. In particular, there are reports of viral protein in up to 100% of GBM specimens. The brain, skin and eyes are not included. OVs are tumor selective and potential anticancer agents. Encouraging good daily oral hygiene, frequent dental visits, and dental fluoride and remineralization supplementation can help counteract the changes induced by insufficient salivation. The percentage of positive HEp-2 cells for 5-bromo-4-chloro-indonyl–D-galactopyranoside (X-gal) staining reached 72% when the cells were transduced with 1106 particles/cell of AAVLacZ.


Br J Cancer 34: 656–659. This review focuses on the risk factors in brief, the pathways as well as biomarkers, and the agents that have been tested for prevention of head and neck malignancies. Discussion: To the best of our knowledge, this is the first report of HSV1 infection on a free flap that was found to be responsible for the free flap appearing distressed. For all three of the cell lines, viral entry assays revealed that the actively migrating cells were significantly more susceptible to herpes infection than the nonmigrating cells. Four cell lines were highly sensitivity to viral cytotoxicity, with >75% of cells lysed by day 6 at MOI 0.1, and two other cell lines were partially susceptible. Gene therapy has the potential for targeting cancer cells while sparing normal tissues. A radical hysterectomy is the removal of the uterus, cervix, ovaries, fallopian tubes and pelvic lymph nodes.

Furthermore, NK LU values were not reflected in standard staging methods, which suggests that the measurement of NK cell function represents an independent prognostic parameter in the patient with head and neck cancer. Atlas Genet Cytogenet Oncol Haematol 2, 145–155, doi: 10.4267/2042/46948 (2012). Although it will be a great challenge to develop robust and reliable molecular diagnostic tests, the development of promising assays fueled by advances in science and technology will continue and will ultimately reach the goal of improving the care of HNC patients. The human oral SCC cell line SAS, Ca9-22 and HSC were obtained from the Japanese Collection of Research Bioresources (Tokyo, Japan). Herpes simplex virus (HSV1) can cause a significant oral infection, with clinical features including erythema and edema in association with transient white vesicles. In all studies performed, the Vaccibody Vaccine Targeting Platform Technology has shown better results than any of the comparators tested at much lower vaccine doses. In this article, we try to approach the immunology of OSCC through a practical approach consideration of common difficulties and dilemmas faced by the oral pathologist, and where possible, we offer guidance and practical tips.

To understand the mechanism of viral interactions in cancer environment the head and neck group of cancers (HNC) are the best ones to follow. Anti-tumor efficacy in vivo was evaluated using subcutaneous and intracranial tumor xenografts of glioma and head and neck cancer. Patients with damaged oral mucosa and reduced immunity resulting from chemotherapy and radiotherapy are also prone to opportunistic infections in the mouth. Results: HSV was detected in nine laryngeal squamous cell carcinomas (75%) and in none of the benign laryngeal lesions (P = .0001). A possible reduction of genotoxicity, mediated by micronutrients, was demonstrated in vitro. Most people don’t realize that sexually transmitted diseases such as herpes, gonorrhea, chlamydia, and human papilloma virus (HPV) can take hold in parts of the oral cavity during sex with infected partners, and that in reverse oral contact can infect the genitals, too. While there have been hints of antitumor efficacy with prolonged survival in some cases compared with historical controls, dramatic responses have been elusive.

Three Phase 1 Studies to evaluate the safety and tolerability of SEPREHVIR in adult patients with primary or recurrent malignant glioma. Expert-reviewed information summary about oral complications, such as mucositis and salivary gland dysfunction, that occur in cancer patients treated with chemotherapy or radiation therapy to the head and neck.